First Time Loading...

Freeline Therapeutics Holdings PLC
NASDAQ:FRLN

Watchlist Manager
Freeline Therapeutics Holdings PLC Logo
Freeline Therapeutics Holdings PLC
NASDAQ:FRLN
Watchlist
Price: 6.48 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

FRLN Price Targets Summary
Freeline Therapeutics Holdings PLC

Wall Street analysts forecast FRLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FRLN is 8.25 USD .

FRLN Lowest Forecast
Wall Street Target
Not Available
FRLN Average Forecast
Wall Street Target
8.25 USD
27% Upside
FRLN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
8.25 USD
27% Upside
Highest
Price Target
Not Available
Freeline Therapeutics Holdings PLC Competitors:
Price Targets
ZYME
Zymeworks Inc
66% Upside
INCY
Incyte Corp
41% Upside
A
APGE
Apogee Therapeutics Inc
61% Upside
CYTH
Cyclo Therapeutics Inc
123% Upside
ZYME
Zymeworks Inc
66% Upside
INCY
Incyte Corp
41% Upside
A
APGE
Apogee Therapeutics Inc
61% Upside
CYTH
Cyclo Therapeutics Inc
123% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
ENLV
Enlivex Therapeutics Ltd
341% Upside
Y
YS
YS Biopharma Co Ltd
477% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
245% Upside

Revenue
Forecast

Revenue Estimate
Freeline Therapeutics Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Freeline Therapeutics Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Freeline Therapeutics Holdings PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
What are analyst estimates?

See Also

Summary
FRLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
FRLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FRLN stock valuation using valuation multiples.
Wall Street Estimates
FRLN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FRLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FRLN's stock price target?
Price Target
8.25 USD

According to Wall Street analysts, the average 1-year price target for FRLN is 8.25 USD .

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.